{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:32:34Z","timestamp":1760056354300,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.diagmicrobio.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:21:09Z","timestamp":1557307269000},"page":"67-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the VIDAS hepatitis E IgM test in a nonendemic region"],"prefix":"10.1016","volume":"95","author":[{"given":"Mercedeh","family":"Tajdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-1279","authenticated-orcid":false,"given":"Marijke","family":"Reynders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2233-7213","authenticated-orcid":false,"given":"Mario","family":"Berth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.02.009","article-title":"Evaluation of two VIDAS \u00aeprototypes for detecting anti-HEV IgG","volume":"89","author":"Abravanel","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcv.2019.01.005","article-title":"Performance characteristics of the VIDAS\u00ae ANTI-HEV IgM and IgG assays","volume":"112","author":"Abravanel","year":"2019","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1708-8305.2006.00049.x","article-title":"Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics","volume":"13","author":"Bottieau","year":"2006","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.14218\/JCTH.2015.00039","article-title":"Hepatitis E: an underdiagnosed, emerging infection in nonendemic regions","volume":"3","author":"De Keukeleire","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2016.05.006","article-title":"Hepatitis E virus infection in the HIV-positive patient","volume":"80","author":"Debes","year":"2016","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL clinical practice guidelines on hepatitis E virus infection","volume":"68","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2009.05.022","article-title":"Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein\u2013Barr virus infection in patients with suspected hepatitis E","volume":"45","author":"Fogeda","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcv.2016.02.021","article-title":"Serologic evidence for hepatitis E virus infection among patients with undifferentiated acute febrile illness in Kibera, Kenya","volume":"77","author":"Furukawa","year":"2016","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15403\/jgld.2014.1121.251.hpe","article-title":"Dutch Autoimmune Hepatitis Study Group. Seroprevalence of hepatitis E virus in autoimmune hepatitis patients in the Netherlands","volume":"25","author":"van Gerven","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/MEG.0b013e32832f5be4","article-title":"Acute hepatitis E infection associated with a false-positive serology against Epstein\u2013Barr virus","volume":"21","author":"Ghinoiu","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/CVI.00231-06","article-title":"Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity","volume":"14","author":"Herremans","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmv.23827","article-title":"Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection","volume":"86","author":"Hyams","year":"2014","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0065","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1111\/j.1365-2893.2011.01477.x","article-title":"Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea","volume":"18","author":"Jang","year":"2011","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2018.05.013","article-title":"Course of HEV viremia and anti-HEV IgM\/IgG response in asymptomatic blood donors","volume":"105","author":"Kraef","year":"2018","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0085","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/CVI.00438-08","article-title":"Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections","volume":"16","author":"Legrand-Abravanel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jcv.2013.10.010","article-title":"Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients","volume":"58","author":"Pas","year":"2013","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.diagmicrobio.2019.04.012_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.006","article-title":"Swiss Autoimmune Hepatitis Cohort Study Group. Autoimmune liver disease serology in acute hepatitis E virus infection","volume":"94","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0105","first-page":"322","article-title":"Hepatitis E seroprevalence in east and west Flanders","volume":"75","author":"Van Hoecke","year":"2012","journal-title":"Acta Gastroenterol Belg"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/v8080232","article-title":"Monitoring of anti\u2013hepatitis E virus antibody seroconversion in asymptomatically infected blood donors: systematic comparison of nine commercial anti-HEV IgM and IgG assays","volume":"8","author":"Vollmer","year":"2016","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.04.012_bb0115","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jmv.23785","article-title":"Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area","volume":"86","author":"Wu","year":"2014","journal-title":"J Med Virol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318305674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318305674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:52:32Z","timestamp":1760003552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318305674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0732889318305674"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.04.012","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the VIDAS hepatitis E IgM test in a nonendemic region","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}